AD Ports, Acino seal global pharma freight forwarding deal

AD Ports, Acino seal global pharma freight forwarding deal

UAE - Leading Swiss pharma group Acino has signed up AD Ports Logistics (ADPL), a subsidiary of the Logistics Cluster, AD Ports Group, to provide global freight forwarding services, inclusive of sea and air transport in Middle East and North Africa (Mena) The agreement will see ADPL leverage its fully integrated and GDP-certified end-to-end pharma cold chain capabilities to transport vital medications from Acino’s global locations of origin to markets in the Mena region. The pharmaceutical products will require specialised transport and handling capabilities offered by ADPL’s Healthcare and Lifesciences division. Under the terms of the agreement, the scope of the freight forwarding services will include first-mile transport, seaport and airport loading, customs clearance, and final-mile logistics. Farook Al Zeer, Chairman of Logistics Cluster at AD Ports Group, said: "We are delighted to have been selected by our partners at Acino as a pharma logistics provider." "The agreement is a significant development opportunity for our Healthcare and Lifesciences division as it allows us to work with a leading global pharmaceutical manufacturer and showcase our capabilities as an enabler of global trade and logistics," he noted. Andrew Bird, Interim CEO of Acino, said: "Our collaboration with AD Ports Group strengthens our